Merit Medical (NSDQ:MMSI) said yesterday that it agreed to acquire Cianna Medical and its breast cancer localization and guidance devices for up to $200 million. Aliso Viejo, Calif.-based Cianna makes the Savi Scout wire-free breast tumor localization system, designed to produce audible and visual indicators surgeons can use to tag cancerous tissue during lumpectomy and biopsy procedures. The device won […]
Merit Medical Systems
Merit Medical closes $217m offering
Merit Medical (NSDQ:MMSI) said yesterday that it closed a stock offering worth more than $217 million after the underwriters picked up their option. South Jordan, Utah-based Merit floated 3.5 million shares at $54 apiece and sold another 525,000 shares in the underwriter’s allotment, for gross proceeds of $217.4 million. The net proceeds of roughly $204.9 million […]
Merit Medical plots public offering
Merit Medical (NSDQ:MMSI) said yesterday that it’s planning a public offering that would reap $200 million at yesterday’s closing price. South Jordan, Utah-based Merit said it intends to float 3.5 million shares in the offering, plus a 30-day underwriters option for another 525,000 shares. Although the medical device maker hasn’t priced the offering, at yesterday’s closing […]
NinePoint Medical lifts Namati to the corner office | Personnel Moves – July 10, 2018
NinePoint Medical said earlier this month that it appointed Eman Namati as its new president and chief executive officer, succeeding Christopher von Jako who will remain on the company’s board of directors. Namati joined NinePoint Medical at its inception in 2010 as a technical co-founder, and operated as R&D VP for the past four years, […]
BD lifts Bard vet DeFord to CTO | Personnel Moves – June 4, 2018
Becton Dickinson (NYSE:BDX) said last Friday it is lifting former C.R. Bard science, technology and clinical affairs senior VP John DeFord to the role of chief technology officer and exec VP. Since acquiring Bard in a $24 billion deal that closed last December, DeFord has served as BD interventional segment R&D SVP, the Franklin Lakes, N.J.-based company […]
Merit Medical gets in on NinePoint’s NvisionVLE OCT
NinePoint Medical said today that it inked a long-term deal with Merit Medical (NSDQ:MMSI) division Endotek to distribute its NvisionVLE optical coherence tomography device that includes strategic investment of an unspecified amount. “NinePoint Medical is committed to providing GI physicians an elegant and cost-effective OCT imaging solution to enable early and accurate diagnosis,” president & CEO Christopher […]
Merit Medical Q1 earnings beat The Street, despite shrinking profits
Shares in Merit Medical (NSDQ:MMSI) have risen slightly today in after hours trading after the medical device maker posted first quarter earnings that beat consensus on Wall Street but saw profits shrink over 50%. The South Jordan, Utah-based company posted profits of $5.3 million, or 10¢ per share, on sales of $203 million for the three […]
Merit Medical’s Q4 earnings top estimates as 2017 profits surge
Merit Medical (NSDQ:MMSI) shares got a jump today from the medical device company’s fourth-quarter results, which beat expectations for both sales and earnings. The South Jordan, Utah-based company yesterday post profits of $6.8 million, or 13¢ per share, on sales of $190.9 million for the three months ended Dec. 31, 2017, for a bottom-line slide of […]
BD closes $100m biopsy assets divestiture to Merit Medical
Becton Dickinson (NYSE:BDX) said today it closed the divestiture of its soft tissue core needle biopsy line and Aspira product line to Merit Medical (NSDQ:MMSI) for $100 million. Assets in the sale include the Achieve programmable automatic biopsy system, Temno biopsy system, Tru-Cut biopsy needles and the Aspira pleural effusion drainage kits and peritoneal drainage systems, Merit Medical […]
Medtech CEOs: Hatch’s last stand should be medtech tax repeal
A trio of medical device CEOs are urging Sen. Orrin Hatch (R-Utah), who’s soon to retire after four decades in the Senate, to make permanent repeal of the medical device tax one of his final acts in office. The 2.3% excise tax on U.S. medical device revenues was in effect for two years before a two-year […]
Medical device companies: These 15 performed the best in 2017
Updated Jan. 5, 2018 Among the most successful medical device companies of 2017, there were two themes: innovation and breadth of services. That was the major takeaway of an MDO analysis of the stock performance of the 100 largest publicly traded medtech companies in the world. What does innovation mean? Think Align Technology (Nasdaq:ALGN) and […]